SEC Form 4 · accession 0001144204-18-013973
ASSEMBLY BIOSCIENCES, INC. · ASMB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Graham K Cooper
Officer — See Remarks
Period of report
Mar 8, 2018
Accepted (ET)
Mar 12, 2018 · 7:21 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001426800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $57.53 | Mar 8, 2018 | A | 220,000 | A | — | Mar 8, 2028 | Common Stock | 220,000 | 220,000 | D |
Explanation of responses
- F1These options vest over three years as follows: one-third will vest on the first anniversary of the date of grant, March 8, 2019; and the remaining two-thirds will vest in 24 equal monthly installments, with the options becoming fully vested on March 8, 2021.
Remarks
Chief Financial Officer and Chief Operating Officer